HMGB3 depletion can sensitize cancer cells to several DNA-damaging drugs [30,31,32,33,34], and given the physical similarities to HMGB1, it is feasible that these two proteins have somewhat redundant functions. The gene discussed is HMGB3; the disease is cancer.